Wang Yaxin#; Xu Binghong#; Ma Sen; Wang Hao; Shang Luqing; Zhu Cheng*; Ye Sheng*;Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Prot ein–Ligand Interactions, International Journal of Molecular Sciences, 2022, 23
点击次数:
上一条:Shi Sai#, Xie Lei#, Ma Sen, Xu Binghong, An Hailong, Ye Sheng*, Wang Yaxin*, Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection, Front. Pharmacol., 02 March 2023.
下一条:Wu Xilin#; Wang Yaxin#; Cheng Lin#; Ni Fengfeng#; Zhu Linjing; Ma Sen; Huang bilian; Ji Mengmeng; Hu Huimin; Li Yuncheng; Xu Shijie; Shi Haixia; Zhang Dongdong; Liu Linshuo; Waqas Nawaz; HuQinxue; Ye Sheng*; Liu Yalan*; Wu Zhiwei*; Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22), Frontiers in Immunology, 2022
